Processa Pharmaceuticals, Inc. Capitalized Computer Software, Gross
Processa Pharmaceuticals, Inc. (PCSA) had Capitalized Computer Software, Gross of $19.74 thousand as of 2020-12-31, per its 10-K filed 2021-03-25.
Discontinued › Notes › Goodwill and Other
us-gaap:CapitalizedComputerSoftwareGross · last filed 2021-03-25
- 2020-12-31: Capitalized Computer Software, Gross $19.74K.
- 2020-03-31: Capitalized Computer Software, Gross $19.74K.
- 2019-12-31: Capitalized Computer Software, Gross $19.74K.
- 2019-09-30: Capitalized Computer Software, Gross $19.74K.
| Period end | Capitalized Computer Software, Gross |
|---|---|
| 2020-12-31 | $19.74K 10-K · filed 2021-03-25 |
| 2020-03-31 | $19.74K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $19.74K 10-K · filed 2021-03-25 |
| 2019-09-30 | $19.74K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $19.74K 10-Q · filed 2019-08-14 |
| 2018-12-31 | $19.74K 10-K · filed 2020-03-06 |
| 2018-09-30 | $19.74K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $19.74K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $19.74K 10-Q · filed 2018-05-21 |
| 2017-12-31 | $19.74K 10-Q · filed 2018-11-14 |
| 2016-12-31 | $15.33K 10-K · filed 2018-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |